Kahira Pharmaceuticals

Last Updated:
  • 36.56 EGP
  • 1.26
  • 3.57%
القاهرة للادوية والصناعات الكيماوية
القاهرة للادوية
Symbol : CPCI
ISIN : EGS38391C016
Day Range : -
Turnover Ratio : 0.12
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Latest Announcements
2022-05-08 07:16:00.0Cairo Pharmaceuticals (CPCI.CA) - Decisions of the Board of Directors' Meeting
2022-04-10 11:34:00.0Cairo Pharmaceuticals (CPCI.CA) - Disclosure Form for the BoD & the Shareholders' Structure
2022-02-24 12:49:00.0Cairo Pharmaceuticals (CPCI.CA) - Listing Committee Decision
2022-02-14 12:37:00.0Cairo Pharmaceuticals (CPCI.CA) - Central Authority of Accountancy Report
2022-02-14 12:31:00.0Cairo Pharmaceuticals (CPCI.CA) - Central Authority of Accountancy Report

Kahira Pharmaceuticals Stock Overview

View Company Profile

Stock Summary

Last Price (EGP) 36.56
Prev. Close 35.300
Day Range 36.56 - 36.90
52WK range
Turnover (M EGP) 0.04
Volume (M) 0.00
Number of Trades 6
Market Cap (M EGP) 552.57
Change in Market Cap (M EGP)
VWAP (EGP) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M EGP)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
  • No Upcoming Events

Cairo – Mubasher: Kahira Pharmaceuticals posted a 22.47% year-on-year (YoY) increase in profits after tax during the first half (H1) of fiscal year...

Cairo – Mubasher: The Egyptian Exchange (EGX) has announced a block trading deal worth EGP 9.24 million on the shares of Kahira...

Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the appointment of Adel Taha Abdel Wahab as the company’s Chairman.The...

Cairo – Mubasher: Kahira Pharmaceuticals achieved net profits of EGP 102.9 million in the first nine months of fiscal year (FY) 2020/2021, up by...

Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the planned budget for fiscal year 2021/2022.The company aims to achieve...